Adrenal Incidentaloma.
Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R, Stewart PM.
Endocr Rev. 2020 Dec 1;41(6):775-820. doi: 10.1210/endrev/bnaa008.
Endocrine gland cancer.
Correa P, Chen VW.
Cancer. 1995 Jan 1;75(1 Suppl):338-52. doi: 10.1002/1097-0142(19950101)75:1+<338::aid-cncr2820751316>3.0.co;2-f.
Molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance.
De Leo A, Ruscelli M, Maloberti T, Coluccelli S, Repaci A, de Biase D, Tallini G.
Virchows Arch. 2024 Feb;484(2):289-319. doi: 10.1007/s00428-023-03713-4. Epub 2023 Dec 18.
Endocrine cancer syndromes: an update.
Anik A, Abaci A.
Minerva Pediatr. 2014 Dec;66(6):533-47. Epub 2014 Sep 22.
Endocrine pathology: past, present and future.
Asa SL, Mete O.
Pathology. 2018 Jan;50(1):111-118. doi: 10.1016/j.pathol.2017.09.003. Epub 2017 Nov 11.
Neoplastic metastases to the endocrine glands.
Angelousi A, Alexandraki KI, Kyriakopoulos G, Tsoli M, Thomas D, Kaltsas G, Grossman A.
Endocr Relat Cancer. 2020 Jan;27(1):R1-R20. doi: 10.1530/ERC-19-0263.
Skin manifestations of endocrine and neuroendocrine tumors.
Leventhal JS, Braverman IM.
Semin Oncol. 2016 Jun;43(3):335-40. doi: 10.1053/j.seminoncol.2016.02.022. Epub 2016 Feb 23.
Topoendocrinology.
Berstein LM.
J Endocrinol. 1993 May;137(2):163-6. doi: 10.1677/joe.0.1370163.
Angiogenesis in endocrine tumors.
Turner HE, Harris AL, Melmed S, Wass JA.
Endocr Rev. 2003 Oct;24(5):600-32. doi: 10.1210/er.2002-0008.
Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events.
Kobayashi T, Iwama S, Arima H.
Endocr J. 2024 Jan 29;71(1):23-29. doi: 10.1507/endocrj.EJ23-0524. Epub 2023 Nov 7.
